Literature DB >> 25755812

A case of immunohistochemical false positive staining caused by incompatibility between a CD4 antibody and an autostainer.

Ikuo Matsuda1, Nao Sugihara2, Hiroshi Yunokizaki3, Takashi Abe3, Seiichi Hirota1.   

Abstract

Precise immunophenotyping of tumor cells by immunohistochemistry is complementary to morphological examination. It is critical for the correct histopathological diagnosis of lymphomas. In this paper, we report a case of T-cell lymphoma whose histopathological diagnosis was confounded by an immunohistochemical pitfall: a false positive caused by incompatibility between an antibody and an autostainer. In this case, based on CD4 immunohistochemistry of the affected lymph nodes, the T-cell lymphoma was diagnosed as CD4-positive at the onset, while it appeared discordantly to be CD4-negative at the second relapse. We noticed that CD4 antibodies and autostainers of different suppliers (designated as suppliers X and Y) were used in an unqualified combination in immunohistochemistry at the onset: that is, the combination of an antibody supplied by X and an autostainer supplied by Y (designated as X-Y combination) was used at the onset. On the other hand, the Y-Y combination was at the second relapse. At the second relapse, flow cytometry of the affected lymph node showed infiltration of CD4-negative T-cell lymphoma. We reasoned that CD4 immunonegativity obtained by the Y-Y combination at the second relapse was specific, while CD4 immunopositivity by the X-Y combination at the onset was false positive. Immunohistochemical reexamination of the lymph node at the onset proved to be CD4-negative by not only the Y-Y but also X-X combinations, confirming our final diagnosis of nodal relapse of CD4-negative T-cell lymphoma. This case illustrates the importance of using compatible combinations of antibodies and autostainers in diagnostic immunohistochemistry.

Entities:  

Keywords:  CD4; Immunohistochemistry; T-cell lymphoma; autostainer; false positive

Mesh:

Substances:

Year:  2015        PMID: 25755812      PMCID: PMC4348898     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  10 in total

1.  SP4, a novel anti-cyclin D1 rabbit monoclonal antibody, is a highly sensitive probe for identifying mantle cell lymphomas bearing the t(11;14)(q13;q32) translocation.

Authors:  Giancarlo Pruneri; Stefano Valentini; Francesco Bertolini; Barbara Del Curto; Eugenio Maiorano; Giuseppe Viale
Journal:  Appl Immunohistochem Mol Morphol       Date:  2005-12

Review 2.  Histiocytic sarcoma in the small intestine: a case report with flow cytometry study and review of the literature.

Authors:  Xiaohong Zhang; John J Kryston; William A Michalak; Kai Zhang; Fan Lin; Conrad Schuerch
Journal:  Pathol Res Pract       Date:  2008-06-09       Impact factor: 3.250

3.  Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies.

Authors:  Sabrina Rossi; Licia Laurino; Alberto Furlanetto; Serena Chinellato; Enrico Orvieto; Fabio Canal; Fabio Facchetti; Angelo P Dei Tos
Journal:  Am J Clin Pathol       Date:  2005-08       Impact factor: 2.493

Review 4.  Isolated juvenile xanthogranuloma in the bone marrow: report of a case and review of the literature.

Authors:  Chimen Kesserwan; Daniel R Boué; Samir B Kahwash
Journal:  Pediatr Dev Pathol       Date:  2007 Mar-Apr

Review 5.  Interdigitating dendritic cell tumor with breast and cervical lymph-node involvement: a case report and review of the literature.

Authors:  Omer Uluoğlu; Nalan Akyürek; Aytuğ Uner; Uğur Coşkun; Ayşegul Ozdemir; Nahide Gökçora
Journal:  Virchows Arch       Date:  2005-04-02       Impact factor: 4.064

6.  Histiocytic lymphoma presenting as a testicular tumour and terminating in acute monoblastic leukaemia.

Authors:  D R Hull; H D Alexander; G M Markey; R W Lyness; T C Morris
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

Review 7.  Primary central nervous system histiocytic sarcoma presenting as a postradiation sarcoma: case report and literature review.

Authors:  Winnie Wu; Asli Tanrivermis Sayit; Harry V Vinters; Whitney Pope; Leili Mirsadraei; Jonathan Said
Journal:  Hum Pathol       Date:  2013-01-26       Impact factor: 3.466

8.  Myeloid leukemia cutis: a histologic and immunohistochemical review.

Authors:  Thomas L Cibull; Antoinette B Thomas; Dennis P O'Malley; Steven D Billings
Journal:  J Cutan Pathol       Date:  2008-02       Impact factor: 1.587

9.  Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance.

Authors:  Junji Hiraga; Akihiro Tomita; Takumi Sugimoto; Kazuyuki Shimada; Masafumi Ito; Shigeo Nakamura; Hitoshi Kiyoi; Tomohiro Kinoshita; Tomoki Naoe
Journal:  Blood       Date:  2009-02-26       Impact factor: 22.113

10.  Consistent immunostaining for cyclin D1 can be achieved on a routine basis using a newly available rabbit monoclonal antibody.

Authors:  Wah Cheuk; Kathy O Y Wong; Cesar S C Wong; John K C Chan
Journal:  Am J Surg Pathol       Date:  2004-06       Impact factor: 6.394

  10 in total
  1 in total

1.  The BRCA2 mutation status shapes the immune phenotype of prostate cancer.

Authors:  Maximilian Jenzer; Peter Keß; Cathleen Nientiedt; Volker Endris; Maximilian Kippenberger; Jonas Leichsenring; Fabian Stögbauer; Josh Haimes; Skyler Mishkin; Brian Kudlow; Adam Kaczorowski; Stefanie Zschäbitz; Anna-Lena Volckmar; Holger Sültmann; Dirk Jäger; Anette Duensing; Peter Schirmacher; Markus Hohenfellner; Carsten Grüllich; Albrecht Stenzinger; Stefan Duensing
Journal:  Cancer Immunol Immunother       Date:  2019-09-23       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.